NewsBenzingaCantor Fitzgerald重申对HubSpot的中性评级，维持200美元目标价 Cantor Fitzgerald重申对HubSpot的中性评级，维持200美元目标价 Benzinga 2026.10.07 11:15 (GMT+0) Open on Benzinga Other news Barclays Maintains Underweight on Allstate, Lowers Price Target to $221 Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $195 Barclays Maintains Underweight on Aflac, Raises Price Target to $101 StoneX Maintains Buy on Imax, Raises Price Target to $65 Barclays Maintains Overweight on 10x Genomics, Raises Price Target to $110 Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100
Barclays Initiates Coverage On Zimmer Biomet Holdings with Equal-Weight Rating, Announces Price Target of $100
